HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering.
HFB301001 是一种基于 OX40 的免疫疗法,通过优化 OX40 受体聚集来驱动 Treg 清除和 CTL 活化。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-014185
Zhao Jiliang, Zhang Dongping, Lu Yun-Yueh, Jin Ruina, Li Fan, Zhang Zhaoyuan, Ni Wentao, Gong Nanxin, Wang Yi, Yin Zhongqian, Du Yazhuo, Ma Wenxuan, Wang Xiaoqian, Zu Lingling, Liu Shiyu, Yang Kailu, Bai Yiyang, Gan Jinping, Adrian Francisco, Hong Zhangyong, Zhang Sihe, Chang Yunsong, Wang Zhenyu, Jin Xin, Zhong Jianguo, Ge Kunkun, Peng Sibo, Ding Dan, Zheng Wei, Xu Song, Wang Wei, Schweizer Liang, Zhang Hongkai